Source: Benzinga

Codiak: Codiak BioSciences Files For Chapter 11 Bankruptcy

Codiak BioSciences Inc (NASDAQ: CDAK) voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and will seek to pursue a sale process for its assets. The company began a marketing process ahead of the Chapter 11 filing to determine the level ...Full story available on Benzinga.com

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Douglas E. Williams's photo - President & CEO of Codiak

President & CEO

Douglas E. Williams

CEO Approval Rating

90/100

Read more